TD Asset Management Inc

Position in CABA — Cabaletta Bio, Inc.

CIK 1056053 Toronto, A6

Position in CABA

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,217,477

+$1,037,452 QoQ

Shares Held

391,472

+485.0% QoQ

Ownership

0.231%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#44

of 139 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. CABA ranks #92 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	259,317	$161,694,522
2	VRTX	Vertex Pharmaceuticals Inc / Ma	207,960	$103,299,970
3	HALO	Halozyme Therapeutics, Inc.	1,115,730	$87,328,187
4	ALNY	Alnylam Pharmaceuticals, Inc.	233,696	$70,349,506
5	CYTK	Cytokinetics Inc	385,130	$32,809,224
6	RPRX	Royalty Pharma plc	567,497	$31,819,556
7	ASND	Ascendis Pharma A/S	119,085	$31,762,351
8	KYMR	Kymera Therapeutics, Inc.	272,900	$31,293,443

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,217,477	391,472	+485.0%	Shares	Sole	2026-08-04
2026-03-31	$180,025	66,924	-24.5%	Shares	Sole	2026-05-11
2025-12-31	$194,034	88,600	0.0%	Shares	Sole	2026-02-10
2025-09-30	$207,324	88,600	0.0%	Shares	Sole	2025-11-10
2025-06-30	$134,672	88,600	0.0%	Shares	Sole	2025-07-28
2025-03-31	$122,711	88,600	0.0%	Shares	Sole	2025-05-07
2024-12-31	$201,122	88,600	0.0%	Shares	Sole	2025-02-11
2024-09-30	$418,192	88,600	-33.9%	Shares	Sole	2024-11-01
2024-06-30	$1,002,544	134,030	+5.5%	Shares	Sole	2024-08-02
2024-03-31	$2,167,131	127,030	+35.7%	Shares	Sole	2024-05-08
2023-12-31	$2,125,401	93,630	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.